LEADER 01512nam  2200397Ia 450 
001 9910699059803321
005 20090818150043.0
035   $a(CKB)5470000002399287
035   $a(OCoLC)430956753
035   $a(EXLCZ)995470000002399287
100   $a20090818d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $efinancial disclosure by clinical investigators
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2001]
215   $a1 online resource
300   $a"Center for Biologics Evaluation and Research".
300   $a"Center for Devices and Radiological Health".
300   $a"March 20, 2001".
517   $aGuidance for industry 
606   $aFinancial disclosure$xGovernment policy$zUnited States
606   $aMedical research personnel$xGovernment policy$zUnited States
615  0$aFinancial disclosure$xGovernment policy
615  0$aMedical research personnel$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Devices and Radiological Health (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699059803321
996   $aGuidance for industry$93434577
997   $aUNINA